FDA Warning Letter — Re-Gen Active Lab Inc
The FDA took a Warning Letter action against Re-Gen Active Lab Inc on May 27, 2022 (Irving, TX). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.
Action details
- Facility
- Re-Gen Active Lab Inc
- Date
- May 27, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Center
- CBER
- Location
- Irving, TX (United States)